Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
暂无分享，去创建一个
A. Toubert | P. Rousselot | F. Mahon | N. Dulphy | F. Guilhot | F. Nicolini | F. Maloisel | F. Huguet | G. Étienne | A. Charbonnier | B. Villemagne | J. Guilhot | D. Réa | H. Moins-Teisserenc | J. Ianotto | V. Dubruille | G. Henry | Zena Khaznadar | L. Legros | M. Gardembas | A. Guerci-Bresler | Guylaine Henry | H. Moins‐Teisserenc